Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Safety Shot, Inc. Appoints CORE IR & PR for Investor Relations, Shareholder Communications and Public Relations Services
-
SUNation Energy Announces Initial Closing of Registered Direct Offering Generating Gross Proceeds of $15 Million
-
Cibus Announces Leadership Change and CEO Succession Plan
-
Astrotech Creates New Subsidiary EN-SCAN, Inc.
-
Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval
-
Inuvo, Inc. Announces Charles D. Morgan's Retirement; Rob Buchner Joins Board
-
Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company’s Continuous Glucose Monitoring Technology
-
Nightfood Holdings, Inc. (NGTF) Provides Update on Strategic Acquisitions and Expansion for 2025
-
SEALSQ to Present at Cantor Global Technology Investor Conference
-
Jamf Announces Upcoming Conferences Participation
-
KE Holdings Inc. Upgraded to ‘A’ in MSCI ESG Rating
-
Nordic Fibreboard AS unaudited financial report for the Q4 and 12 months of 2024
-
FRO – Q4 2024 Presentation
-
CHMP recommends EU approval of Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma
-
HostColor Expands Edge Bare Metal Server Hosting Options
-
Bitget Spreads Kindness This Ramadan by Providing 100,000 Meals to Those in Need
-
Safe & Green Holdings Corp. Regains Compliance with Nasdaq Continued Listing Requirements
-
Safe & Green Holdings Corp. Regains Compliance with Nasdaq Continued Listing Requirements
-
Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration
-
Alliance Witan PLC - Net Asset Value
-
Jasper Therapeutics Announces Late-Breaking Briquilimab Presentation at the American Academy of Dermatology (AAD) Annual Meeting
-
Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025
-
Repeat: TREATMENT.COM AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) BOUGHT DEAL PRIVATE PLACEMENT
-
Praxis Precision Medicines Provides Update on Essential3 and Corporate Update
-
Archipelo Emerges from Stealth with $12M in Funding to Tackle the Next Frontier in Cybersecurity: Developer Security Posture Management
-
Daniella C. Vespoli Joins Calfee, Halter & Griswold Law Firm as Corporate and Finance Partner
-
Opus One Gold Corporation Announces Grant of Stock Options
-
Serve Robotics to Present at Cantor Global Technology Conference
-
AMD Unveils Next-Generation AMD RDNA™ 4 Architecture with the Launch of AMD Radeon™ RX 9000 Series Graphics Cards
-
Orderly Integrates Berachain to Enhance Access to Omnichain Liquidity
-
Fluent Announces Unaudited Fourth Quarter and Full-Year 2024 Financial Results
-
Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays
-
Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call
-
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended December 31, 2024 and Declaration of Distributions on Common Stock for the Months Ending Apri
-
Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates
-
Daniella C. Vespoli Joins Calfee, Halter & Griswold Law Firm as Corporate and Finance Partner
-
MEDIA ALERT: Lancôme and Well+Good Present the Recovery Portal
-
Modern Aviation Partners with the City of Charlotte to Manage its FBO at Charlotte Douglas International Airport
-
SailPoint Announces Date of Fiscal Q4 and Full Year 2025 Earnings Conference Call
-
Alignment Healthcare to Present at the Leerink Global Healthcare Conference and KeyBanc Capital Markets Healthcare Forum
-
Daxor Expands Blood Volume Analysis Services at Major Midwest Healthcare Center
-
Nayax Announces the Acquisition of UPPay
-
Scatec completes sale of African hydropower assets to TotalEnergies for USD 167 million
-
Avance Gas Holding Ltd: Key information relating to extraordinary dividend of $0.75 per share
-
Banco Santander Chile Announces the Filing of Its Annual Report on Form 20-F With the United States Securities and Exchange Commission for Fiscal Year 2024
-
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
-
Avance Gas Holding Ltd: Closing of the sale of the MGC fleet and extraordinary dividend of $0.75 per share
-
Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)
-
AGF Investments Launches AGF Enhanced U.S. Income Plus Fund
-
Compass Lexecon Enhances Capabilities with Appointment of Prominent Economist Ginger Jin

